| Name (Synonyms) | Correlation | |
|---|---|---|
| drug313 | Azithromycin Wiki | 0.17 |
| drug1284 | Hydroxychloroquine Wiki | 0.10 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D013577 | Syndrome NIH | 0.10 |
| D055371 | Acute Lung Injury NIH | 0.10 |
| D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.09 |
| D012128 | Respiratory Distress Syndrome, Adult NIH | 0.08 |
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
The aim of the study is to evaluate the safety, improvement of clinical symptoms and laboratory parameters of convalescent immune plasma treatment in severe Covid-19 patients with ARDS.
Description: Acute phase reactant
Measure: Plasma ferritin level Time: 7. dayDescription: Infection markers
Measure: Lymphocyte count Time: 7. dayDescription: Hypercoagulability
Measure: D-Dimer level Time: 7. dayDescription: Infection markers
Measure: C-Reactive protein level Time: 7. dayDescription: Infection markers
Measure: Plasma procalcitonin level Time: 7. dayDescription: Coagulopathy
Measure: Plasma fibrinogen level Time: 7. dayDescription: Arterial oxygenation
Measure: Fractional Inspired Oxygen Level Time: 7. dayDescription: Arterial oxygenation
Measure: Partial Oxygen Saturation level Time: 7. dayDescription: Arterial oxygenation
Measure: Arterial Oxygen level Time: 7. day